DOC Utility: Screening of Depression, Obstructive Sleep Apnea and Cognitive Impairment

Sponsor
Dr. Richard H. Swartz (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02363114
Collaborator
Canadian Institutes of Health Research (CIHR) (Other)
6,500
1
104
62.5

Study Details

Study Description

Brief Summary

The primary objective of this study is to determine whether baseline DOC screening can add to clinical and demographic data to predict the occurrence of a composite negative outcome (any of: recurrent stroke, myocardial infarction, death, or admission to a long-term care (LTC) / complex continuing care (CCC) facility) within one year of screening, in stroke prevention clinic patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The DOC screen will be routinely applied to all patients presenting to three high volume Regional Stroke Prevention Clinics (combined first visits >2,800 patients per year). Data will be abstracted from the patient chart using methodologies developed and validated in the Registry of the Ontario Stroke Network. The investigators have REB approval to collect this data and to link with administrative datasets through the Institute for Clinical and Evaluative Sciences (ICES). The investigators will use regression models to determine whether DOC screen scores add to baseline clinical and demographic data to predict the main negative outcomes. The investigators hope to identify which patients presenting to TIA/stroke prevention clinics are at highest risk of adverse long-term events so focused interventions can be developed to improve survival, outcomes and function of stroke prevention clinic patients.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    6500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    DOC Utility: Simple Screening of Depression, Obstructive Sleep Apnea and Cognitive Impairment to Identify Stroke Clinic Patients at Risk of Adverse Outcomes
    Actual Study Start Date :
    Apr 1, 2014
    Actual Primary Completion Date :
    Sep 30, 2017
    Anticipated Study Completion Date :
    Dec 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Stroke Prevention Clinic Patients

    All consecutive patients presenting to six high volume Regional Stroke Prevention Clinics.

    Outcome Measures

    Primary Outcome Measures

    1. Number of Participants with any Adverse Event [1 Year from Initial Screen Date]

      A composite negative outcome will be created, defined as the occurrence of any recurrent stroke, myocardial infarction, death, or admission to a long-term care (LTC) / complex continuing care (CCC) facility within one year of screening.

    Secondary Outcome Measures

    1. Number of Participants with recurrent stroke [1 Year from Initial Screen Date]

      The number of participants with the occurrence of recurrent stroke within one year of screening

    2. Incidence of DOC co-morbidities [1 Year from Initial Screen Date]

      To describe the incidence of DOC co-morbidities and outcomes in clinical important sub-groups (e.g. stroke-in-the-young, women vs. men, stroke in the "oldest-old" patients, TIA vs. ischemic stroke

    3. Number of Participants with myocardial infarction [1 Year from Initial Screen Date]

      The number of participants with the occurrence of myocardial infarction within one year of screening

    4. Number of Participants who died [1 Year from Initial Screen Date]

      The number of participants who died within one year of screening

    5. Number of Participants who have been admitted to a long-term care or complex continuing care facility [1 Year from Initial Screen Date]

      The number of participants who have been admitted to a long-term care or complex continuing care facility within one year of screening

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Consecutive patients referred to regional stroke prevention clinics.

    • This includes those discharged from hospital with a diagnosis of stroke or TIA, as well as emergency department referrals.

    • The DOC CRF will also be completed for patients who are unable to complete the screen due to severe aphasia, severe motor dysfunction and language barriers (those who are not fluent in English without translation available).

    Exclusion Criteria:
    • Patients whose reason for referral to the clinic is neither Stroke nor TIA, as well as those who have been admitted to LTC/CCC facilities at the time of clinic visit.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sunnybrook Health Sciences Centre Toronto Ontario Canada M4N 3M5

    Sponsors and Collaborators

    • Dr. Richard H. Swartz
    • Canadian Institutes of Health Research (CIHR)

    Investigators

    • Principal Investigator: Richard H Swartz, MD, PHD, Sunnybrook Health Sciences Centre

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr. Richard H. Swartz, Principle Investigator, Sunnybrook Health Sciences Centre
    ClinicalTrials.gov Identifier:
    NCT02363114
    Other Study ID Numbers:
    • 141-2014
    • 1012404
    First Posted:
    Feb 13, 2015
    Last Update Posted:
    Sep 22, 2021
    Last Verified:
    Sep 1, 2021

    Study Results

    No Results Posted as of Sep 22, 2021